☆ 4.7 Meeting Abstract

Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19)

JOURNAL OF CLINICAL ONCOLOGY (2020)

Journal

JOURNAL OF CLINICAL ONCOLOGY

Volume 38, Issue 18, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1200/JCO.2020.38.18_suppl.LBA110

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

Gowri Satyanarayana, Kyle T. Enriquez, Tianyi Sun, Elizabeth J. Klein, Maheen Abidi, Shailesh M. Advani, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Marilia Bernardes, Pamela C. Egan, Arielle Elkrief, Lawrence E. Feldman, Christopher R. Friese, Shipra Goel, Cyndi Gonzalez Gomez, Keith L. Grant, Elizabeth A. Griffiths, Shuchi Gulati, Shilpa Gupta, Clara Hwang, Jayanshu Jain, Chinmay Jani, Anna Kaltsas, Anup Kasi, Hina Khan, Natalie Knox, Vadim S. Koshkin, Daniel H. Kwon, Chris Labaki, Gary H. Lyman, Rana R. McKay, Christopher McNair, Gayathri Nagaraj, Elizabeth S. Nakasone, Ryan Nguyen, Taylor K. Nonato, Adam J. Olszewski, Orestis A. Panagiotou, Matthew Puc, Pedram Razavi, Elizabeth Robilotti, Miriam Santos-Dutra, Andrew L. Schmidt, Dimpy P. Shah, Sumit A. Shah, Kendra Vieira, Lisa B. Weissmann, Trisha M. Wise-Draper, Ulysses Wu, Julie Tsu-Yu Wu, Toni K. Choueiri, Sanjay Mishra, Jeremy L. Warner, Benjamin French, Dimitrios Farmakiotis

Summary: This study aimed to investigate the frequency of coinfections and their association with outcomes among patients with cancer and COVID-19. The results showed that the risk of coinfections in this population was associated with factors such as age, sex, comorbidities, and disease status. Bacterial and fungal coinfections were found to be associated with higher mortality rates, while viral coinfections were less common.

OPEN FORUM INFECTIOUS DISEASES (2022)

Add to Collection

Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas, A. R. Khaki, T. M. Wise-Draper, B. French, C. Hennessy, C-Y Hsu, Y. Shyr, X. Li, T. K. Choueiri, C. A. Painter, S. Peters, B. Rini, M. A. Thompson, S. Mishra, D. R. Rivera, J. D. Acoba, M. Z. Abidi, Z. Bakouny, B. Bashir, T. Bekaii-Saab, S. Berg, E. H. Bernicker, M. A. Bilen, P. Bindal, R. Bishnoi, N. Bouganim, D. W. Bowles, A. Cabal, P. F. Caimi, D. D. Chism, J. Crowell, C. Curran, A. Desai, B. Dixon, D. B. Doroshow, E. B. Durbin, A. Elkrief, D. Farmakiotis, A. Fazio, L. A. Fecher, D. B. Flora, C. R. Friese, J. Fu, S. M. Gadgeel, M. D. Galsky, D. M. Gill, M. J. Glover, S. Goyal, P. Grover, S. Gulati, S. Gupta, S. Halabi, T. R. Halfdanarson, B. Halmos, D. J. Hausrath, J. E. Hawley, E. Hsu, M. Huynh-Le, C. Hwang, C. Jani, A. Jayaraj, D. B. Johnson, A. Kasi, H. Khan, V. S. Koshkin, N. M. Kuderer, D. H. Kwon, P. E. Lammers, A. Li, A. Loaiza-Bonilla, C. A. Low, M. B. Lustberg, G. H. Lyman, R. R. McKay, C. McNair, H. Menon, R. A. Mesa, V Mico, D. Mundt, G. Nagaraj, E. S. Nakasone, J. Nakayama, A. Nizam, N. L. Nock, C. Park, J. M. Patel, K. G. Patel, P. Peddi, N. A. Pennell, A. J. Piper-Vallillo, M. Puc, D. Ravindranathan, M. E. Reeves, D. Y. Reuben, L. Rosenstein, R. P. Rosovsky, S. M. Rubinstein, M. Salazar, A. L. Schmidt, G. K. Schwartz, M. R. Shah, S. A. Shah, C. Shah, J. A. Shaya, S. R. K. Singh, M. Smits, K. E. Stockerl-Goldstein, D. G. Stover, M. Streckfuss, S. Subbiah, L. Tachiki, E. Tadesse, A. Thakkar, M. D. Tucker, A. K. Verma, D. C. Vinh, M. Weiss, J. T. Wu, E. Wulff-Burchfield, Z. Xie, P. P. Yu, T. Zhang, A. Y. Zhou, H. Zhu, L. Zubiri, D. P. Shah, J. L. Warner, GdL Lopes

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Article Oncology

COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry

Hala T. Borno, Mi-Ok Kim, Julian C. Hong, Sasha Yousefi, Amy Lin, Irina Tolstykh, Sylvia Zhang, Rana R. McKay, Olivier Harismendy, Pelin Cinar, Hope Rugo, Vadim S. Koshkin, Maya Rabow, Christine Wang, Adina Bailey, Eric J. Small

Summary: This study observed that patients with active cancer or advanced age are at an increased risk of death from COVID-19. These study observations can inform risk counseling for patients with cancer regarding COVID-19.

ONCOLOGIST (2022)

Add to Collection

Article Oncology

COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients

Beth Russell, Charlotte L. Moss, Kieran Palmer, Rushan Sylva, Andrea D'Souza, Harriet Wylie, Anna Haire, Fidelma Cahill, Renee Steel, Angela Hoyes, Isabelle Wilson, Alyson Macneil, Belul Shifa, Maria J. Monroy-Iglesias, Sophie Papa, Sheeba Irshad, Paul Ross, James Spicer, Shahram Kordasti, Danielle Crawley, Kamarul Zaki, Ailsa Sita-Lumsden, Debra Josephs, Deborah Enting, Angela Swampillai, Elinor Sawyer, Paul Fields, David Wrench, Anne Rigg, Richard Sullivan, Mieke Van Hemelrijck, Saoirse Dolly

Summary: The study found that male, Black or Asian ethnicity, and patients with hematological malignancies are at an increased risk of COVID-19. Using cancer patients as the COVID-19 negative comparator group is a major advantage to the study, helping better understand the true impact of COVID-19 on cancer patients.

CANCERS (2021)

Add to Collection

Article Oncology

Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium

Karlijn de Joode, Jolien Tol, Paul Hamberg, Marissa Cloos, Elisabeth A. Kastelijn, Jessica S. W. Borgers, Veerle J. A. A. Nuij, Yarne Klaver, Gerarda J. M. Herder, Pim G. N. J. Mutsaers, Daphne W. Dumoulin, Esther Oomen-de Hoop, Nico G. J. van Diemen, Eduard J. Libourel, Erica J. Geraedts, Gerben P. Bootsma, Cor H. van der Leest, Anne L. Peerdeman, Karin H. Herbschleb, Otto J. Visser, Haiko J. Bloemendal, Hanneke W. M. van Laarhoven, Elisabeth G. E. de Vries, Lizza E. L. Hendriks, Laurens Beerepoot, Hans M. Westgeest, Franchette W. P. J. van den Berkmortel, John B. A. G. Haanen, Anne-Marie C. Dingemans, Astrid A. M. van der Veldt

Summary: This study aimed to investigate the clinical patient characteristics related to COVID-19 outcomes and advanced care planning in cancer patients. The study found that patients with hematological malignancies or lung cancer were at a higher risk of fatal outcomes compared to other solid tumors, and there was no correlation between anticancer therapies and the risk of fatal COVID-19 outcomes. Timely end-of-life communication and early discussion of treatment restrictions should be part of routine oncological care, especially during the COVID-19 pandemic.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

Aljosja Rogiers, Ines Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M. Grimes, Megan H. Trager, Sharon Nahm, Leyre Zubiri, Michael Manos, Peter Bowling, Arielle Elkrief, Neha Papneja, Maria Grazia Vitale, April A. N. Rose, Jessica S. W. Borgers, Severine Roy, Joanna Mangana, Thiago Pimentel Muniz, Tim Cooksley, Jeremy Lupu, Alon Vaisman, Samuel D. Saibil, Marcus O. Butler, Alexander M. Menzies, Matteo S. Carlino, Michael Erdmann, Carola Berking, Lisa Zimmer, Dirk Schadendorf, Laura Pala, Paola Queirolo, Christian Posch, Axel Hauschild, Reinhard Dummer, John Haanen, Christian U. Blank, Caroline Robert, Ryan J. Sullivan, Paolo Antonio Ascierto, Wilson H. Miller, F. Stephen Hodi, Karijn P. M. Suijkerbuijk, Kerry L. Reynolds, Osama E. Rahma, Paul C. Lorigan, Richard D. Carvajal, Serigne Lo, Mario Mandala, Georgina Long

Summary: This study investigated the impact of immune checkpoint inhibition (ICI) on the severity of COVID-19 in cancer patients infected with SARS-CoV-2. The findings showed that mortality related to COVID-19 in ICI-treated cancer patients did not appear to be higher than previously reported rates for cancer patients, although inpatient mortality was high compared to hospitalized cancer patients overall. Factors associated with adverse outcomes in ICI-treated patients with COVID-19 were also identified.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Oncology

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

Judy C. Boughey, Rebecca A. Snyder, Olga Kantor, Linda Zheng, Akhil Chawla, Toan T. Nguyen, Shauna L. Hillman, Olwen M. Hahn, Sumithra J. Mandrekar, Christina L. Roland

Summary: The COVID-19 pandemic has impacted cancer clinical trials, with changes such as healthcare workers and study coordinators working remotely, patients minimizing visits to medical facilities, and a drop in trial accrual at the onset of the pandemic. Adjustments were made to trial protocols to allow telephone or video-enabled consent, and some study activities were shifted to local healthcare providers or laboratories to facilitate patient participation during these challenging times.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Infectious Diseases

Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19

Hiromu Tanaka, Ho Lee, Atsuho Morita, Ho Namkoong, Shotaro Chubachi, Hiroki Kabata, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Norihiro Harada, Tetsuya Ueda, Soichiro Ueda, Takashi Ishiguro, Ken Arimura, Fukuki Saito, Takashi Yoshiyama, Yasushi Nakano, Yoshikazu Mutoh, Yusuke Suzuki, Koji Murakami, Yukinori Okada, Ryuji Koike, Yuko Kitagawa, Katsushi Tokunaga, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai, Koichi Fukunaga

Summary: This study conducted host genome analysis of hospitalized patients with COVID-19 in Japan and found a relatively high number of severe cases but a relatively low case fatality rate.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Psychology, Multidisciplinary

Psychological Impact of COVID-19 on Parents of Pediatric Cancer Patients

Antonella Guido, Elisa Marconi, Laura Peruzzi, Nicola Dinapoli, Gianpiero Tamburrini, Giorgio Attina, Mario Balducci, Vincenzo Valentini, Antonio Ruggiero, Daniela Pia Rosaria Chieffo

Summary: This study aimed to investigate the psychological impact of the COVID-19 pandemic on parents of pediatric cancer patients, revealing high levels of anxiety and stress among parents. The study also found positive correlations between psychological trauma and perceived stress, as well as between stress and children's quality of life.

FRONTIERS IN PSYCHOLOGY (2021)

Add to Collection

Article Infectious Diseases

Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

Shiro Otake, Shotaro Chubachi, Ho Namkoong, Kensuke Nakagawara, Hiromu Tanaka, Ho Lee, Atsuho Morita, Takahiro Fukushima, Mayuko Watase, Tatsuya Kusumoto, Katsunori Masaki, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Norihiro Harada, Tetsuya Ueda, Soichiro Ueda, Takashi Ishiguro, Ken Arimura, Fukuki Saito, Takashi Yoshiyama, Yasushi Nakano, Yoshikazu Mutoh, Yusuke Suzuki, Koji Murakami, Yukinori Okada, Ryuji Koike, Yuko Kitagawa, Akinori Kimura, Seiya Imoto, Satoru Miyano, Seishi Ogawa, Takanori Kanai, Koichi Fukunaga

Summary: This study used cluster analysis to phenotype COVID-19 patients in Japan and identified four distinct clusters. Patients in the middle-aged obese and elderly clusters had a higher prevalence of shortness of breath and higher levels of serum biomarkers. The middle-aged obese cluster had worse outcomes but a lower mortality rate.

BMC INFECTIOUS DISEASES (2022)

Add to Collection

Article Green & Sustainable Science & Technology

The impact of COVID-19 on air pollution: Evidence from global data

Suborna Barua, Shobod Deba Nath

Summary: This study examines the impact of increased mobility during the COVID-19 period on carbon monoxide emissions. It finds that increased indoor mobility leads to a reduction in emissions, while outdoor mobility increases at places like transit stations, workplaces, and retail areas drive up emissions. Short-term effects are limited, but long-term effects show significant impacts. Overall, reducing unnecessary outdoor mobility could help maintain air quality in the post-pandemic world.

JOURNAL OF CLEANER PRODUCTION (2021)

Add to Collection

Article Oncology

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

Michael J. Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann, Diana Vilar-Compte, Erika Ruiz-Garcia, Matthew Ingham, Gary K. Schwartz, Corrie A. Painter, Rashmi Chugh, Leslie Fecher, Cathleen Park, Olga Zamulko, Jonathan C. Trent, Vivek Subbiah, Ali Raza Khaki, Lisa Tachiki, Elizabeth S. Nakasone, Elizabeth T. Loggers, Chris Labaki, Renee Maria Saliby, Rana R. McKay, Archana Ajmera, Elizabeth A. Griffiths, Igor Puzanov, William D. Tap, Clara Hwang, Sachin R. Jhawar, Brandon Hayes-Lattin, Elizabeth Wulff-Burchfield, Anup Kasi, Daniel Y. Reuben, Gayathri Nagaraj, Monika Joshi, Hyma Polimera, Amit A. Kulkarni, Khashayar Esfahani, Daniel H. Kwon, Luca Paoluzzi, Mehmet A. Bilen, Eric B. Durbin, Petros Grivas, Jeremy L. Warner, Elizabeth J. Davis

Summary: Patients with sarcoma have a higher risk of developing complications from COVID-19, and patients with bone sarcoma may be at a greater risk of death from COVID-19. Older age, poor performance status, and lung metastases are risk factors for more severe COVID-19.

CANCERS (2022)

Add to Collection

Article Immunology

Impact of prior vaccination on clinical outcomes of patients with COVID-19

Woo Jung Seo, Jiyeon Kang, Hyung Koo Kang, So Hee Park, Hyeon-Kyoung Koo, Hye Kyeong Park, Sung-Soon Lee, Je Eun Song, Yee Gyung Kwak, Jieun Kang

Summary: A study on COVID-19 patients found that vaccination significantly reduces the risk of pneumonia and requirement for supplemental oxygen, as well as shortens hospital stay. Vaccination is a critical factor in reducing the occurrence of pneumonia and severe disease when breakthrough infection happens. Therefore, it is vital to continuously increase vaccine coverage in populations.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Article Endocrinology & Metabolism

Glycemic Control and Clinical Outcomes in US Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database

Rachel Wong, Margaret Hall, Rohith Vaddavalli, Adit Anand, Neha Arora, Carolyn T. Bramante, Victor Garcia, Steven Johnson, Mary Saltz, Jena S. Tronieri, Yun Jae Yoo, John B. Buse, Joel Saltz, Joshua Miller, Richard Moffitt

Summary: In a large multicenter cohort of T2D patients with COVID-19 infection in the US, a higher HbA(1c) level was found to be associated with an increased risk of hospitalization. The risk of death and invasive ventilation also increased but plateaued at different levels of glycemic control. There was no significant difference in length of stay across different HbA(1c) levels.

DIABETES CARE (2022)

Add to Collection

Article Oncology

Cancer in Lockdown: Impact of the COVID-19 Pandemic on Patients with Cancer

Harsha Moraliyage, Daswin De Silva, Weranja Ranasinghe, Achini Adikari, Damminda Alahakoon, Raj Prasad, Nathan Lawrentschuk, Damien Bolton

Summary: Patients with cancer have turned to social media platforms during the COVID-19 pandemic to express concerns about delayed diagnosis, treatment cancellations, missed treatments, and weakened immunity. The emotional well-being of these patients remains largely unexplored and underreported, despite the use of remote health technologies to address medical needs.

ONCOLOGIST (2021)

Add to Collection

Article Oncology

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)

Vishal Navani, J. Connor Wells, Devon J. Boyne, Winson Y. Cheung, Darren M. Brenner, Bradley A. McGregor, Chris Labaki, Andrew L. Schmidt, Rana R. McKay, Luis Meza, Sumanta K. Pal, Frede Donskov, Benoit Beuselinck, Maxwell Otiato, Lisa Ludwig, Thomas Powles, Bernadett E. Szabados, Toni K. Choueiri, Daniel Y. C. Heng

Summary: Limited data exists regarding the efficacy of cabozantinib following contemporary first line therapy options in advanced kidney cancer. A real world database analysis of 346 patients revealed clinically meaningful activity of second line cabozantinib after all evaluated contemporary first line therapies, including immune checkpoint blockade combination approaches.

CLINICAL GENITOURINARY CANCER (2023)

Add to Collection

Review Pathology

Primary neuroendocrine tumors and primary neuroendocrine carcinomas of the liver: a proposal for a multidiscipline definition

Michael Torbenson, Sudhakar K. Venkatesh, Thorvardur R. Halfdanarson, Patrick J. Navin, Patrick Kamath, Lori A. Erickson

Summary: Primary hepatic neuroendocrine tumors and primary hepatic neuroendocrine carcinomas are rare and challenging to diagnose if they are primary to the liver or metastatic. The lack of a uniform definition for primary hepatic neuroendocrine neoplasms hinders understanding and treatment of these rare tumors. This article proposes a multidisciplinary definition and guidelines for diagnosing a neuroendocrine tumor/neuroendocrine carcinomas as being primary to the liver.

HUMAN PATHOLOGY (2023)

Add to Collection

Editorial Material Oncology

Risk Model Development and Validation in Clinical Oncology: Lessons Learned

Gary H. Lyman, Pavlos Msaouel, Nicole M. Kuderer

Summary: This article summarizes key considerations related to risk modeling in clinical oncology, including data quality, missing data, sample size estimation, and variable selection. The importance of rigorous internal validation and careful examination of model stability and quality is emphasized.

CANCER INVESTIGATION (2023)

Add to Collection

Article Oncology

Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma

Akram M. Shayeb, Hannah Dzimitrowicz McManus, Danielle Urman, Chinmay Jani, Tian Zhang, Nazli Dizman, Luis Meza, Akhilesh Sivakumar, Chun L. Gan, Pedro Barata, Mehmet A. Bilen, Xin Gao, Daniel Heng, Sumanta Pal, Ravi Narra, Deepak Kilari, Marina D. Kaymakcalan, Bradley McGregor, Toni K. Choueiri, Rana R. McKay

Summary: In this retrospective multicenter study, the safety of cabozantinib with different anticoagulants in patients with advanced RCC was investigated. The study found that DOACs appear to be safe for VTE treatment in patients on cabozantinib without increasing the risk of major bleeding events. Optimized anticoagulation management remains vital in clinical practice.

CLINICAL GENITOURINARY CANCER (2023)

Add to Collection

Article Oncology

Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States

Amro M. Abdelrahman, Jun Yin, Roberto Alva-Ruiz, Jennifer A. Yonkus, Jennifer L. Leiting, Isaac T. Lynch, Alessandro Fogliati, Nellie A. Campbell, Danielle M. Carlson, Lewis R. Roberts, Gregory J. Gores, Rory L. Smoot, Rondell P. Graham, Thorvardur R. Halfdanarson, Mark J. Truty

Summary: Mixed acinar neuroendocrine carcinoma of the pancreas (MANEC-P) is an extremely rare and aggressive malignancy. This study aimed to estimate and compare the incidence, prevalence, and cancer-specific survival of MANEC-P in the United States. The results showed a steady incidence rate of MANEC-P over the last two decades, with a poor prognosis and being the 5th leading cause of pancreatic cancer-related death in the US.

CANCERS (2023)

Add to Collection

Editorial Material Oncology

ASO Visual Abstract: Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases-Long-Term Follow-Up of Over 500 Patients

Hallbera Gudmundsdottir, Elizabeth B. Habermann, Robert A. Vierkant, Patrick Starlinger, Cornelius A. Thiels, Susanne G. Warner, Rory L. Smoot, Mark J. Truty, Michael L. Kendrick, Thorvardur R. Halfdanarson, David M. Nagorney, Sean P. Cleary

ANNALS OF SURGICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients

Hallbera Gudmundsdottir, Elizabeth R. B. Habermann, Robert A. A. Vierkant, Patrick Starlinger, Cornelius A. A. Thiels, Susanne G. G. Warner, Rory L. L. Smoot, Mark J. J. Truty, Michael L. L. Kendrick, Thorvardur R. R. Halfdanarson, David M. M. Nagorney, Sean P. P. Cleary

Summary: This retrospective analysis examined patients who underwent cytoreductive hepatectomy for liver metastases from neuroendocrine tumors. The study found that the surgery can relieve symptoms and prolong survival, with low morbidity and mortality rates. It also showed that functional tumors can achieve durable symptomatic relief.

ANNALS OF SURGICAL ONCOLOGY (2023)

Add to Collection

Article Cell Biology

Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma

Julie Stein Deutsch, Evan J. Lipson, Ludmila Danilova, Suzanne L. Topalian, Jaroslaw Jedrych, Ezra Baraban, Yasser Ged, Nirmish Singla, Toni K. Choueiri, Saurabh Gupta, Robert J. Motzer, David McDermott, Sabina Signoretti, Michael Atkins, Janis M. Taube

Summary: H&E scoring of tumor-infiltrating immune cells (TILplus) using light microscopy in pre-treatment tumor specimens is associated with improved overall survival in patients with clear cell renal cell carcinoma.

CELL REPORTS MEDICINE (2023)

Add to Collection

Letter Oncology

Reply to Residual Tumor Volume, Not Percent Cytoreduction, Matters for Surgery of Neuroendocrine Liver Metastasis

Hallbera Gudmundsdottir, Sean P. Cleary, Thorvardur R. Halfdanarson

ANNALS OF SURGICAL ONCOLOGY (2023)

Add to Collection

Editorial Material Oncology

Perception, Cognition and Thought: Part V Entropy, the Arrow of Time and the Present

Gary H. Lyman, Christopher H. Lyman, Nicole M. Kuderer

CANCER INVESTIGATION (2023)

Add to Collection

Review Oncology

Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment

Nikolaos Andreatos, Patrick W. W. McGarrah, Mohamad Bassam Sonbol, Jason S. S. Starr, Jaume Capdevila, Halfdan Sorbye, Thorvardur R. R. Halfdanarson

Summary: This review evaluates the second-line and later therapeutic options for extrapulmonary neuroendocrine carcinoma (EP-NEC) and explores potential future developments. Promising regimens, such as systemic therapy combinations and novel checkpoint inhibitors, are gradually being utilized in the second-line setting. Advances in understanding disease biology are also helping to refine patient selection and identify targeted therapy options. While there are still many questions to be answered, contemporary developments provide grounds for optimism regarding improved outcomes for EP-NEC.

CURRENT ONCOLOGY REPORTS (2023)

Add to Collection

Review Oncology

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

Thorvardur R. Halfdanarson, Nadine Mallak, Scott Paulson, Chandrikha Chandrasekharan, Mona Natwa, Ayse Tuba Kendi, Hagen F. Kennecke

Summary: This article discusses the best practices in radioligand therapy for GEP-NETs patients, including imaging, clinical biochemistry, and tumor assessment criteria. Effective monitoring and surveillance measures are crucial for personalized clinical decision-making in individual clinical circumstances.

CANCERS (2023)

Add to Collection

Review Biology

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies

Leonidas N. Diamantopoulos, Markos Kalligeros, Thorvardur R. Halfdanarson, Nikolaos Diamantis, Christos Toumpanakis

Summary: There are various systemic combination regimens being investigated for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This review provides an overview of the clinical trials and prospective studies on combination treatments. Results show a wide range of efficacy in reported combinations, and only a few phase 3 trials have shown practice-changing results. Peptide receptor radionuclide therapy (PRRT)-based combinations and anti-vascular endothelial growth factor (VEGF) agent combinations with standard chemotherapy have shown promising results, while immune-checkpoint inhibitor-based combinations have limited applicability.

BIOLOGY-BASEL (2023)

Add to Collection

Letter Oncology

Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma

Thomas Powles, Joseph E. Burgents, Lei Xu, Toni K. Choueiri

LANCET ONCOLOGY (2023)

Add to Collection

Article Oncology

Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19

Cristiane Decat Bergerot, Jasnoor Malhotra, Paulo Bergerot, Errol J. Philip, Daniela V. Castro, JoAnn Hsu, Augusto Cesar de Andrade Mota, Andressa Cardoso de Azeredo, Joo Nunes de Matos Neto, Thomas Hutson, Viktor Gruenwald, Axel Bex, Sarah P. Psutka, Brian Rini, Elizabeth R. Plimack, Viraj Master, Laurence Albiges, Toni K. Choueiri, Sumanta Pal, Thomas Powles

Summary: This study explored the perceived relevance of items in the FKSI-19 questionnaire among patients with mRCC. The most relevant items were fatigue, lack of energy, and worry about disease progression, while least relevant items included blood in urine, fevers, and lack of appetite. Patients also raised additional issues related to emotional and physical symptoms, family, treatment effectiveness, spirituality, and financial toxicity.

ONCOLOGIST (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.